Close Menu

NEW YORK (GenomeWeb) – Interpace Diagnostics announced after the close of the market on Tuesday that its third quarter revenues grew 38 percent year over year, surpassing the consensus Wall Street estimate.

For the three months ended Sept. 30, the Parsippany, New Jersey-based firm posted $5.8 million in revenues compared to $4.2 million in the year-ago period. It beat the analysts' average estimate of $5.6 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.